检索结果 - Colin Powers

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Rhesus CMV: an emerging animal model for human CMV

    Rhesus CMV: an emerging animal model for human CMV 由 Colin Powers, Klaus Früh

    出版 2008
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Dehydrated Human Amnion Chorion Membrane as Treatment for Pediatric Burns

    Dehydrated Human Amnion Chorion Membrane as Treatment for Pediatric Burns 由 Natasha Ahuja, Richard M Jin, Colin Powers, Alexandria Billi, Kathryn D. Bass

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes

    Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes 由 Amy Ku, Jason B. Muhitch, Colin Powers, Michael Diehl, Minhyung Kim, Daniel T. Fisher, Anand P. Sharda, Virginia K. Clements, Kieran L. O’Loughlin, Hans Minderman, Michelle N. Messmer, Jing Ma, Joseph J. Skitzki, Douglas A. Steeber, Bruce Walcheck, Suzanne Ostrand‐Rosenberg, Scott I. Abrams, Sharon S. Evans

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Survival benefit associated with liver transplantation for hepatocellular carcinoma based on tumor burden scores at listing

    Survival benefit associated with liver transplantation for hepatocellular carcinoma based on tumor burden scores at listing 由 Hao Liu, Wei Zhang, Mengyang Di, Hang Lee, Liuhua Shi, Xixi Wang, Xingyu Zhang, Colin Powers, Vrishketan Sethi, Xingjie Li, Yao Xiao, Andrew Crane, Christof Kaltenmeier, Ramon Bataller Alberola, Jaideep Behari, Andrés Duarte‐Rojo, Dempsey L. Hughes, Shahid M. Malik, Naudia Jonassaint, David A. Geller, Samer Tohme, Vikraman Gunabushanam, Amit D. Tevar, Ruy J. Cruz, Christopher Hughes, Stalin Dharmayan, Subhashini Ayloo, Abhinav Humar, Michele Molinari

    出版 2025
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19

    Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19 由 Long Mao, Namir Shaabani, Xiaoying Zhang, Can Jin, Wanhong Xu, Christopher Argent, Yulia Kushnareva, Colin Powers, Karen Stegman, Jia Liu, Huimin Xie, Changxu Xu, Yimei Bao, Lijun Xu, Yuren Zhang, Haigang Yang, Shengdian Qian, Yong Hu, Jianping Shao, Can Zhang, Tingting Li, Yi Li, Na Liu, Zhenhao Lin, Shanbo Wang, Chao Wang, Weiliang Shen, Yuanlong Lin, Dan Shu, Zhenhong Zhu, Olivia Kotoi, Lisa Kerwin, Qing Han, Ludmila Chumakova, John R. Teijaro, Mike A. Royal, Mark Brunswick, Robert D. Allen, Henry Ji, Hongzhou Lu, Xiaohong Xu

    出版 2024
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: